Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

82.93 -0.65 (-0.78%)
Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about DexCom, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Is It Time to Buy July's Worst-Performing Nasdaq Stocks?
These three Nasdaq stocks saw price drops of more than 35% last month. Are they good buys or too risky to touch today? 
Via The Motley Fool
Down 40% in 1 Day, Is DexCom Stock Still a Buy?
Competition and new growth headwinds could derail the stock even further. 
Via The Motley Fool
Here's How Much You Would Have Made Owning DexCom Stock In The Last 15 Years
Via Benzinga
DoorDash And Exact Sciences Are Among Top 10 Large Cap Gainers Last Week (July 28-Aug 3): Are The Others In Your Portfolio?
Top 10 stocks with highest gains last week, including Exact Sciences, Alnylam Pharmaceuticals, Resmed, Coca-Cola Consolidated, DexCom, Sprouts Farmers Market, UL Solutions, Labcorp Holdings, C.H.... 
Via Benzinga
As Diabetes Battle Heats Up, Spotlight Turns To Dexcom, Abbott
Dexcom is taking on bigger rival Abbott Laboratories with a continuous glucose monitor for non insulin users. 
Via Investor's Business Daily
Demystifying DexCom: Insights From 15 Analyst Reviews
Via Benzinga
Behind the Scenes of DexCom's Latest Options Trends
Via Benzinga
Despite its growth, NASDAQ:DXCM remains within the realm of affordability.
In the world of growth stocks, NASDAQ:DXCM shines as a value proposition. 
Via Chartmill
Jim Cramer Says This Home Improvement Chain Is A Buy Ahead Of Fed Rate Cut Cycle: 'I Would Pick Some Up Tomorrow'
Jim Cramer recommends buying Blackstone Inc. (BX) due to its strong companies and expects Lowe's (LOW) stock to benefit from Federal Reserve's rate cut. 
Via Benzinga
Topics Economy
Top 3 Health Care Stocks That May Explode In Q3
Via Benzinga
Market Momentum: Your Weekly Financial Forecast
Originally published at VolumeLeaders What to expect for July 29- August 02, 2024 
Via Benzinga
DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame?
DexCom faces several challenges, but GLP-1 drugs aren't big problems for the company right now. 
Via The Motley Fool
Why DexCom Stock Is Crashing Today
Investors are worried about the diabetes care technology leader's slowing growth. 
Via The Motley Fool
ON Semiconductor Posts Upbeat Earnings, Joins Oil States International, CommScope Holding And Other Big Stocks Moving Higher On Monday
Via Benzinga
Is Beaten-Down Dexcom Stock a Buy on the Dip?
The market may have overreacted to a disappointing earnings report. 
Via The Motley Fool
2 Unstoppable Growth Stocks to Buy Right Now for Less Than $1,000
These profitable businesses have a lot to offer the long-term investor. 
Via The Motley Fool
2 Magnificent Growth Stocks to Buy Right Now
These top stocks are looking increasingly attractive for a long-term investment. 
Via The Motley Fool
S&P 500 Gains Over 1%; 3M Shares Jump After Q2 Results
Via Benzinga
Topics Stocks
Wall Street Enjoys Late-Week Rally On Benign Inflation Data, Dow Jones Eyes Best Session Of 2024, Tech Unwinding Stalls: What's Driving Markets Friday?
After a turbulent week in the markets, the bulls reclaimed dominance on Wall Street during Friday’s session, with indices and sectors trading in positive territory as investors welcomed the latest... 
Via Benzinga
Topics Economy Stocks
Dow Recovers Weekly Losses With 600-Point Pop
The Dow Jones Industrial Average is soaring today, up 608 points at last look and breaking into positive territory for the week. 
Via Talk Markets
Topics Stocks
Crude Oil Down Over 2%; Bristol Myers Squibb Posts Upbeat Q2 Results
Via Benzinga
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
DexCom Faces Short-Term Challenges, But Market Growth Prospects Remain Strong: Analyst
DexCom reports Q2 sales of $1.004B, up 15% YoY, with adjusted EPS of $0.43, beating the $0.39 consensus. Despite lowering 2024 sales guidance to $4.00-$4.05B, William Blair maintains an Outperform... 
Via Benzinga
Why DexCom Stock Is Trading Lower Friday
DexCom shares are trading lower Friday after the company reported worse-than-expected second quarter revenue and issued weak guidance. 
Via Benzinga
Kroger and Albertsons Pause Merger Deal: KR and ACI Stocks on Watch
Kroger and Albertsons are gearing up for a Colorado lawsuit that has put the combination of the two grocery companies on hold. 
Via InvestorPlace
Topics Lawsuit
Stock Market Diverges, With Tesla, Google, ServiceNow, GE In Focus: Weekly Review
Small caps continued to lead, while the Nasdaq broke below key levels. 
Via Investor's Business Daily
Dexcom (DXCM) Stock Is Plunging on an ‘Execution Miss.’ What Is Really Going On?
Dexcom's Stelo faces an uncertain future thanks to drugs like Wegovy and a competing Abbott Labs product. DXCM stock is down 40% today. 
Via InvestorPlace
LTM Stock IPO: 7 Things to Know as LATAM Airlines Returns to the NYSE
LATAM Airlines stock is back on the NYSE alongside an IPO for LTM shares after they were delisted from the market back in 2020. 
Via InvestorPlace
Topics Initial Public Offering
Why Is Zynex (ZYXI) Stock Down 24% Today?
Zynex stock is falling on Friday as ZYXI investor react to earnings misses and poor guidance for Q3 and the full year of 2024. 
Via InvestorPlace
Topics Earnings
Why Is DexCom (DXCM) Stock Down 38% Today?
DexCom stock is up on Friday as DXCM investors react to the company's latest earnings report and its lackluster 2024 guidance. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
27 28 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.